Adia Med Reports No Serious Adverse Events in First Pediatric Autism Study Cohort
Adia Med reported no serious adverse events in either study arm in the first cohort. Enrollment and participant follow-up continue.
Adia Med reported no serious adverse events in either study arm in the first cohort. Enrollment and participant follow-up continue.